SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001513160-12-000065
Filing Date
2012-09-13
Accepted
2012-09-13 13:19:13
Documents
7
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 OXIS QUARTERLY REPORT AMENDMENT NO. 1 oxis10qa06302012.htm 10-Q/A 28500
  Complete submission text file 0001513160-12-000065.txt   2103080

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT oxis-20120630.xml EX-101.INS 300267
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oxis-20120630.xsd EX-101.SCH 24599
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oxis-20120630_cal.xml EX-101.CAL 31790
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT oxis-20120630_def.xml EX-101.DEF 55390
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oxis-20120630_lab.xml EX-101.LAB 175926
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oxis-20120630_pre.xml EX-101.PRE 127833
Mailing Address 468 N. CAMDEN DR. 2ND FLOOR BEVERLY HILLS CA 90210
Business Address 468 N. CAMDEN DR. 2ND FLOOR BEVERLY HILLS CA 90210 (310) 551-4020
OXIS INTERNATIONAL INC (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-08092 | Film No.: 121089663
SIC: 2834 Pharmaceutical Preparations